Home  |  Contact

Cellosaurus DIF3-17 (CVCL_UF12)

[Text version]
Cell line name DIF3-17
Accession CVCL_UF12
Resource Identification Initiative To cite this cell line use: DIF3-17 (RRID:CVCL_UF12)
Comments Population: African; Kenyan.
Characteristics: Strongly resistant to both the antiviral and antiproliferative actions of interferons.
Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
Cell type: B-cell; CL=CL_0000236.
Sequence variations
  • Gene fusion; HGNC; 5477; IGH + HGNC; 7553; MYC; Name(s)=MYC-IGH (from parent cell line).
  • Mutation; HGNC; 914; B2M; Simple; p.Met1Ile (c.3G>C); Zygosity=Homozygous (from parent cell line).
  • Mutation; HGNC; 2514; CTNNB1; Simple; p.Ala5_Ala80del (c.14_241del228); Zygosity=Homozygous (from parent cell line).
  • Mutation; HGNC; 11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
Disease EBV-related Burkitt lymphoma (NCIt: C27694)
Burkitt lymphoma (ORDO: Orphanet_543)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_UF11 (DIF3)
Sex of cell Male
Age at sampling 16Y
Category Cancer cell line
Publications

PubMed=3785169; DOI=10.1128/mcb.6.5.1374-1378.1986
Dron M., Modjtahedi N., Brison O., Tovey M.G.
Interferon modulation of c-myc expression in cloned Daudi cells: relationship to the phenotype of interferon resistance.
Mol. Cell. Biol. 6:1374-1378(1986)

Cross-references
Cell line databases/resources cancercelllines; CVCL_UF12
Encyclopedic resources Wikidata; Q93527510
Entry history
Entry creation13-Nov-2018
Last entry update05-Oct-2023
Version number11